These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34756502)

  • 1. A concise framework to facilitate open COVID pledge of non-disclosed technologies: In terms of non-disclosed patent applications and trade secrets.
    Wang RL; Shen CL; Wu TC; Hsiao WW
    J Formos Med Assoc; 2022 Aug; 121(8):1425-1430. PubMed ID: 34756502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fortifying Health Care Intellectual Property Transactions With Blockchain.
    Liang HW; Chu YC; Han TH
    J Med Internet Res; 2023 Aug; 25():e44578. PubMed ID: 37594787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal 3D printing: Patent law, trade secrets, and additive manufacturing.
    Rimmer M
    Front Res Metr Anal; 2022; 7():958761. PubMed ID: 36118015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. University patenting and licensing practices in the United Kingdom during the first year of the COVID-19 pandemic.
    Keestra S; Rodgers F; Osborne R; Wimmer S
    Glob Public Health; 2022 May; 17(5):641-651. PubMed ID: 35298347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protecting Trade Secrets in Canada.
    Courage N; Calzavara J
    Cold Spring Harb Perspect Med; 2015 May; 5(9):a024489. PubMed ID: 25986591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring risks of investor claims brought forth after the TRIPS waiver for COVID-19.
    Kulkarni SM; Kaur V
    Pharm Pat Anal; 2022 Nov; 11(6):165-174. PubMed ID: 36314462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and IP Rights: A Multifaceted Relationship.
    Durell K
    Methods Mol Biol; 2016; 1404():791-811. PubMed ID: 27076338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COVID-19 Pandemic and the TRIPS Waiver: Patents and Flexibility.
    Lawson C; Rourke M
    J Law Med; 2022 Aug; 29(3):663-676. PubMed ID: 36056658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Short Introduction to Intellectual Property Rights.
    Voss T; Paranjpe AS; Cook TG; Garrison NDW
    Tech Vasc Interv Radiol; 2017 Jun; 20(2):116-120. PubMed ID: 28673648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Information Disclosed in Patent Documents being the Source to Address Emergencies: A Strategy to Achieve Technological Developments Addressing COVID-19.
    Martins TD; Cordeiro DS
    Recent Pat Biotechnol; 2021 Oct; 15(2):148-163. PubMed ID: 33797389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
    Crager SE; Guillen E; Price M
    Am J Law Med; 2009; 35(2-3):253-79. PubMed ID: 19697749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intellectual property-The Foundation of Innovation: A scientist's guide to intellectual property.
    Poticha D; Duncan MW
    J Mass Spectrom; 2019 Mar; 54(3):288-300. PubMed ID: 30676684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Global Intellectual Property Waiver is Still Needed to Address the Inequities of COVID-19 and Future Pandemic Preparedness.
    Amin T; Kesselheim AS
    Inquiry; 2022; 59():469580221124821. PubMed ID: 36124939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constraints on gene patent protection fuel secrecy concerns: a qualitative study.
    Guerrini CJ; McGuire AL; Majumder MA; Bollinger JM; Rowan PJ
    J Law Biosci; 2017 Dec; 4(3):542-564. PubMed ID: 29868184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent pledges, open IP, or patent pools? Developing taxonomies in the thicket of terminologies.
    Ehrnsperger JF; Tietze F
    PLoS One; 2019; 14(8):e0221411. PubMed ID: 31430349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When speed matters: a discussion on the benefits of a grace period in patent law to accelerate pharmaceutical innovation in times of pandemic.
    Ozyhar T; Barnabei L; Myrick D
    J Law Biosci; 2022; 9(1):lsac004. PubMed ID: 35233290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual Property Rights and Vaccines.
    Gilbert P; Fawcett R; Coles J; Hillson W
    Methods Mol Biol; 2022; 2412():505-518. PubMed ID: 34918265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intellectual property.
    Brown WM
    Methods Mol Med; 2000; 40():227-41. PubMed ID: 21337093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.